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Abstract Low B vitamin status is linked with human
vascular disease. We employed a proteomic and bio-
chemical approach to determine whether nutritional folate
deficiency and/or hyperhomocysteinemia altered metabolic
processes linked with atherosclerosis in ApoE null mice.
Animals were fed either a control fat (C; 4 % w/w lard) or
a high-fat [HF; 21 % w/w lard and cholesterol (0/15 %
w/w)] diet with different B vitamin compositions for
16 weeks. Aorta tissue was prepared and global protein
expression, B vitamin, homocysteine and lipoprotein status
measured. Changes in the expression of aorta proteins were
detected in response to multiple B vitamin deficiency
combined with a high-fat diet (P\ 0.05) and were strongly
linked with lipoprotein concentrations measured directly in
the aorta adventitia (P\ 0.001). Pathway analysis revealed
treatment effects in the aorta-related primarily to cyto-
skeletal organisation, smooth muscle cell adhesion and
invasiveness (e.g., fibrinogen, moesin, transgelin, vimen-
tin). Combined B vitamin deficiency induced striking
quantitative changes in the expression of aorta proteins in
atherosclerotic ApoE null mice. Deregulated expression of
these proteins is associated with human atherosclerosis.
Cellular pathways altered by B vitamin status included
cytoskeletal organisation, cell differentiation and migra-
tion, oxidative stress and chronic inflammation. These
findings provide new insight into the molecular mecha-
nisms through which B vitamin deficiency may accelerate
atherosclerosis.
Keywords Aorta proteome  ApoE null mice 
Atherosclerosis  B vitamins  Hyperhomocysteinemia
Introduction
Low dietary folate is strongly associated with an increased
risk of human vascular diseases including atherosclerosis
and stroke (Voutilainen et al. 2000, 2004; Durga et al.
2005). This has been attributed primarily to suboptimal
intracellular folate, together with low levels of vitamins
B12 and B6, inducing hyperhomocysteinemia (Splaver et al.
2004). However, there is evidence for folate alone influ-
encing human vascular disease. High circulating folate is
associated with reduced risk of primary coronary events
and carotid intima-media thickness independently of total
plasma homocysteine in several prospective human studies
(Voutilainen et al. 2000, 2004; Durga et al. 2005). More-
over, supplemental folic acid positively influences vascular
function in patients with, or at risk of, vascular disease
(Mangoni et al. 2005; Tawakol et al. 2005; Till et al. 2005).
These effects appear largely independent of homocysteine.
Determining whether low folate or hyperhomocystein-
emia is causal for vascular disease in vivo is difficult due to
the intimate metabolic relationship linking folate and
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homocysteine. Transgenic mouse strains provide a repre-
sentative model of human atherosclerosis and allow com-
plete investigation of the effect of diet on vascular disease
progression. The ApoE knockout mouse spontaneously
develops atherosclerotic plaques that are morphologically
analogous to lesions found in human tissue (Zhang et al.
2002). We have developed distinct nutritional deficiencies
in transgenic ApoE null mice so that they exhibit either
mild or moderate hyperhomocysteinemia (McNeil et al.
2011). We have shown that B vitamin deficiency increases
atherosclerotic plaque formation in transgenic ApoE
knockout mice and that this is strongly linked with accu-
mulation of cholesterol and pro-atherogenic lipoproteins in
the adventitial lipid surrounding the aorta (McNeil et al.
2011, 2012).
Proteomic technologies have been widely used to
identify quantitative changes in protein expression as a
consequence of several human vascular pathologies
including atherosclerosis, aorta medial degeneration and
myocardial revascularisation (Wu et al. 2007; Delbosc
et al. 2008; Farina et al. 2010). Moreover, they have proven
to be powerful tools in rodents studies for providing
mechanistic insight into how vascular disease progresses
and is influenced by environmental factors such as diet
(Mayr et al. 2005; Almofti et al. 2006).
Here, we employed a combined biochemical and quan-
titative global proteomics approach to determine how
prolonged nutritional folate deficiency and/or moderate
hyperhomocysteinemia differentially modulates global
protein expression directly in the aorta of ApoE null mice
and to further identify whether these changes are associated
with proteins and processes involved in the progression of
human atherosclerosis.
Materials and methods
Animal study and diets
The design of this animal study and the composition of
the experimental diets employed have been described in
detail elsewhere (McNeil et al. 2011, 2012). All proce-
dures were carried out in accordance with the require-
ments of the UK Animals (Scientific Procedures) Act
1986. ApoE null mice (males, 5 weeks old) were allo-
cated (by weight) to one of six treatment groups (n = 10
animals per group). Diets were based on either a control
[C; 4 % w/w lard] or high-fat [HF; 21 % w/w lard and
cholesterol (0.15 % w/w)] background with different B
vitamin compositions applied to each (1) folic acid and B
vitamin replete, (2) folic acid depleted (F–), or (3) folic
acid, B6 and B12 depleted (F–B–). Mice were fed these
diets for 16 weeks.
Blood and aorta collection
Mice were fasted up to 6 h and killed by exsanguination
under terminal anaesthesia. Blood was collected from the
vena cava for analysis of B vitamins, homocysteine and
lipoproteins. Residual blood was flushed from the heart by
injection of Dulbecco’s modified Eagles medium (DMEM)
into the left ventricle. The complete aorta was microdis-
sected of tunica adventitia. The thoracic and abdominal
aorta and the dissected adventitia were snap-frozen and
stored at -80 C for proteomic and lipid analysis. The
aortic arch was fixed in 10 % formalin and atherosclerotic
plaque volume quantified by staining plaques in situ with
the neutral lipid-targeting lysochrome Oil Red O (ORO,
Sigma, Poole, UK), which targets fatty acid deposits in the
arterial plaques and solubilising and measuring spectro-
photometrically the dye retained in the aorta. Solubilised
ORO as a biomarker of atherosclerotic plaque volume was
corrected for aorta tissue weight (Beattie et al. 2009;
McNeil et al. 2011, 2012).
Preparation of aorta tissue for proteomic analyses
Weighed frozen aorta (approx. 10 mg) was added to
extraction buffer containing 7 M urea, 2 M thiourea, 4 %
CHAPS and 2 % BioRad Biolite Ampholyte pH 3–10 and
homogenised using a Precellys 24 lysis and homogenisa-
tion cycler (Stretton Scientific, UK). The homogenate was
centrifuged at 14,000 rpm for 5 min at 4 C and the
supernatant frozen at -80 C. Protein was measured using
the BioRad RC DC protein assay.
2D gel electrophoresis of aorta tissues
One 2D gel was run per aorta (100 lg) sample (n = 10 mice
per treatment group; 60 gels in total). Proteins were sepa-
rated by isoelectric focusing in the first dimension [BioRad
immobilised pH gradient (IPG) strips (pi range 3–10)] and
SDS-PAGE in the second dimension on 8–16 acrylamide
gels (18 9 18 cm) as described previously (Duthie et al.
2008). Gels were stained with Coomassie blue and imaged
on a BioRad GS710 flat bed imager followed by image
analysis using PD Quest version 8.0.1. Spots were excised
from the gels using a robotic BioRad spot cutter, trypsinised
in a MassPrep Station (Waters, MicroMass, Manchester,
UK) and analysed by LC MS/MS using an Ultimate nano
LC capillary chromatography system (LC Packings, Cam-
berly, Surrey, UK), combined with an Applied Biosystems
2000 Q-Trap (Warrington, UK). Peak list were generated
using Analyst 1.4.2 software set at default. Peptide fragment
mass spectra yielded a sequence of separated peptides that
were pasted into the fingerprinting web resource programme
Mascot dll version 1.6b9 (Matrix Science Ltd, Boston, MA)
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for protein identification. Protein identification was made
using SWISS-PROT (version 2012.09) specifically for Mus
musculus (mouse), with expectation values, cut-off scores
and threshold values for individual proteins considered.
Protein confidence parameters including Mowse scores,
expected and actual masses, PI, number of unique peptides
matched, percentage sequence coverage and gene and pro-
tein accession numbers, together with protein function, are
shown for each identified peptide in the experimental results
(Supplementary Table 1).
B vitamin and lipoprotein analyses
Blood and tissue folate and B12 were measured by radio-
assay and plasma total homocysteine by gas chromatog-
raphy (McNeil et al. 2011, 2012). Lipid was extracted from
adventitial tissue (approx. 200 mg) (Folch et al. 1957) and
total cholesterol, LDL cholesterol, HDL cholesterol, TG
and NEFA fractions measured in plasma and aorta
adventitial lipid using a Konelab 20 Clinical Chemistry
Analyser (Thermo Scientific, Passau, Germany). Fatty
acids were trans-esterified to methyl esters (FAMEs) in
methanolic HCL, separated by liquid–liquid solvent
extraction and measured by gas–liquid chromatography
(GLC; Burdge et al. 2000).
Statistical analysis
For proteomic analysis, 2D gel images were studied using
PDQuest software (BioRad). After normalisation and
matching, spot densities were exported for data analysis
(multivariate) using Excel and ‘‘R’’ (R Foundation for
Statistical Computing, Vienna, Austria; version 2.10). Log
transformed spot densities from aorta tissue were analysed
by two-way ANOVA for the effect of fat intake, vitamin
composition and interaction between these factors
(P\ 0.05). These analyses provide quantitative protein
expression data, as densitometry of the Coomassie-stained
spots is carried out for each animal in each treatment group
individually prior to statistical analysis.
Biochemical data were analysed by two-way ANOVA
for the effect of fat intake, vitamin composition and
interaction between these factors. Significant differences
between all groups were detected using the least significant
difference (LSD) post hoc method. Analysis of associations
among aorta tissue protein expression and blood B vitamin
status markers, blood and vascular lipids, and atheroscle-
rotic plaque volume was carried out for all mice in all
treatment groups using Pearson’s correlation coefficients.
Spots with densities that differed significantly either due to
treatment (P\ 0.05) or were highly correlated with B
vitamin and lipid status at the end of the study (P\ 0.001)
were excised from the gel and identified by LC MS/MS.
Association networks between biochemical biomarkers and
protein expression were displayed using Cytoscape soft-
ware (version 2.8.3; http://www.cytoscape.org). Principal
component analysis (PCA) of the physiological biomarkers
measured from each mouse in the study was carried out and
the component scores calculated.
Results
B vitamin, homocysteine, lipid status and aorta plaque
volume
Principal component analysis (PCA) of biochemical data
for all animals revealed that the treatment phenotypes
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Fig. 1 Primary component
analysis (PCA) score plot of
blood and tissue biomarkers
significantly altered by folic
acid, B vitamins and fat intake
in ApoE null mice. Mice were
fed a control (C) or high-fat
(HF) diet depleted of folic acid
(F–) or folic acid and vitamins
B6 and B12 (F–B–) for
16 weeks. Symbols represent
individual replicate animals
within every treatment group
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separated differentially according to fat intake and folate
and B vitamin treatment (Fig. 1). Aortic plaque volume,
blood and lipid biomarkers are shown in Table 1. Folate
was depleted more than 65 % in mice fed a folate-deficient
diet. B12 decreased more than 70 % in animals fed the
combined folate and B vitamin-depleted diet. Folate defi-
ciency increased homocysteine twofold. Homocysteine
was elevated further in mice fed a combined B vitamin-
depleted diet (approx. fourfold). B12 depletion and hype-
rhomocysteinemia were exacerbated by high fat. Total
cholesterol was increased in aorta adventitial lipid in
response to a high-fat diet. Plasma cholesterol, HDL and
LDL were elevated (approx. twofold). Folate depletion
alone did not impact on circulating or adventitial lipids.
However, feeding a combined folate and B vitamin-defi-
cient diet exacerbated cholesterol accumulation and
significantly reduced MUFA and increased pro-atherogenic
SATFAs in the aorta adventitial lipid. Plaque volume was
increased almost twofold (P\ 0.0001) in mice fed a HF
diet for 16 weeks when compared with animals on a con-
trol diet (Table 1). Plaque volume was significantly
increased (17 %; P\ 0.05) in mice depleted of folic acid.
Imposing a combined B vitamin deficiency did not increase
plaque development further (Table 1).
Atherosclerotic plaque abundance was correlated
strongly with circulating and vascular lipid levels, and
weakly with plasma vitamin B12 (Table 2). Plaque forma-
tion did not correlate directly either with blood folate or
homocysteine. However, whole blood and plasma B12 did
strongly influence both circulating and adventitial lipid
concentrations, with low B12 associated with high levels of
plasma TG, adventitial total cholesterol and SATFAs and,
Table 1 The effect of folic acid, B vitamins and dietary fat intake on B vitamin, homocysteine and plasma and aorta adventitial lipid status in
ApoE null mice
Biomarkers Control fat High fat
C C–F C–F–B HF HF–F HF–F–B
B vitamin status
Plasma folate (ng/ml) 87.8 ± 4.8a 16.2 ± 1.5b 14.9 ± 0.9b 104.9 ± 5.5c 15.5 ± 1.7b 15.0 ± 1.4b
Whole blood folate (ng/ml) 498.9 ± 42.9a 163.5 ± 8.9b 184.7 ± 6.8b 507.9 ± 26.0a 149.6 ± 9.7b 193.3 ± 18.7b
Plasma B12 (ng/ml) 24.8 ± 2.3
a 15.3 ± 1.0b 6.8 ± 0.1c 25.6 ± 3.0a 12.5 ± 0.5d 6.1 ± 0.5c
Whole blood B12 (ng/ml) 22.5 ± 1.0
a,c 22.0 ± 0.6a,c 7.2 ± 0.7b 24.9 ± 1.6a 20.5 ± 1.1c 6.9 ± 1.0b
Plasma homocysteine (lM) 7.8 ± 0.4a 18.1 ± 1.9b 28.4 ± 3.6c 6.7 ± 0.3a 14.2 ± 1.0b 45.5 ± 4.3d
Plasma lipids
Total cholesterol (mmol/L) 12.7 ± 0.51a 10.9 ± 0.61b 12.9 ± 0.40a,b 26.2 ± 1.92c 26.5 ± 0.96c 24.9 ± 1.34c
HDL cholesterol (mmol/L) 5.22 ± 0.33a 5.51 ± 0.84a 5.71 ± 0.92a 9.23 ± 0.40b 10.42 ± 0.87b 8.86 ± 0.59b
LDL cholesterol (mmol/L) 9.25 ± 0.38a 8.04 ± 0.42b 8.90 ± 0.52a,b 24.19 ± 1.85c 24.79 ± 1.11c 22.58 ± 1.06c
Triglycerides (TG) (mmol/L) 1.15 ± 0.05a,c 1.27 ± 0.08a 2.20 ± 0.25b 0.89 ± 0.14c,e 1.01 ± 0.08c,d,e 0.91 ± 0.07e
Aorta adventitial lipids
Total cholesterol
(mmol/g lipid)
35.1 ± 4.7a,c 24.1 ± 2.1b 33.0 ± 3.0a 43.1 ± 4.6a,c 53.4 ± 8.4c,d 73.4 ± 9.1d
HDL cholesterol
(mmol/g lipid)
ND ND ND 1.0 ± 1.0 1.6 ± 1.4 6.1 ± 4.1
NEFA (mmol/g lipid) 6.9 ± 0.9a 5.8 ± 0.8a 7.5 ± 1.3a,b 7.5 ± 0.8a,b 9.1 ± 1.4a,b 10.2 ± 1.0b
Triglycerides (TG)
(lmol/g lipid)
919.0 ± 35.0a,b 849.0 ± 58.7a,c 880.6 ± 45.3a,b,c 856.9 ± 61.6a,b,c 1,032.7 ± 63.1b 798.7 ± 23.1c
SATFAs (% total fat) 31.14 ± 1.15a,b 30.84 ± 0.69a 33.38 ± 0.84b 27.84 ± 0.59c 28.81 ± 0.46c 33.89 ± 0.49b,d
MUFAs (% total fat) 47.38 ± 0.08a,b 47.36 ± 0.44a,b 46.11 ± 0.49a 48.33 ± 0.67b 48.60 ± 0.55b,c 42.45 ± 0.69d
PUFAs (% total fat) 20.76 ± 1.02a,b 21.10 ± 0.70a,b 19.56 ± 0.84a 22.53 ± 0.54b 21.77 ± 0.30b,c 22.61 ± 0.64b,d
Aorta plaque volume
(nM/mg tissue)
0.274 ± 0.014a 0.260 ± 0.018a 0.261 ± 0.007a 0.556 ± 0.024b 0.637 ± 0.027c 0.602 ± 0.030b,c
These data are reproduced with the kind permission of the journals, Clinical Epigenetics (McNeil et al. 2011) and Molecular Nutrition and Food
Research (McNeil et al. 2012)
Mice were fed a control (C) or high-fat (HF) diet depleted of folic acid (F–) or folic acid and vitamins B6 and B12 (F–B–) for 16 weeks. Values
are mean ± SEM for n = 9–10 mice sampled per group. Biochemical data were analysed by two-way ANOVA for the effect of fat intake,
vitamin composition and interaction between these factors. Significant differences between all groups were detected using the least significant
difference (LSD) post hoc method. Data not sharing superscript letters differ by P\ 0.05. B12 vitamin B12, HDL high-density lipoprotein, LDL
low-density lipoprotein, MUFAs monounsaturated fatty acids, PUFAs polyunsaturated fatty acids, NEFA non-esterified fatty acids, SATFAs
saturated fatty acids
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conversely, a lower proportion of MUFAs. Low folate was
similarly associated with accumulation of SATFAs in the
aorta adventitia. Hyperhomocysteinemia was positively
associated with elevated SATFA and reduced MUFA
concentrations in the adventitia (Table 2).
Aorta tissue proteomics
Comparative quantitative proteomics revealed approxi-
mately 800 spots in the aorta samples that matched across
all 60 treatment gels. The primary proteins (approx. 35 %
of total identified proteins) influenced by treatment in the
aorta were involved in regulating cytoskeletal organisation,
cell adhesion and cell motility (Fig. 2). Mean (and group
SEM) spot densities for aorta proteins that differed
between treatment groups (P\ 0.05) are shown in Table 3.
The independent effects of fat or vitamin treatment on
protein expression are described (P values) together with
the synergistic effect of a HF and combined vitamin-
depleted diet. The effect of B6 and B12 depletion, above
folate deficiency alone is also shown. Vitamin depletion
alone altered expression of only six aorta proteins [fibrin-
ogen, gelsolin, glutamate dehydrogenase 1, lactate dehy-
drogenase and talin-1 (all upregulated) and peptidyl-prolyl
cis–trans isomerise A (downregulated)]. Feeding a com-
bined vitamin-deficient and high-fat diet had a strong
synergistic effect on 25 aorta proteins (including derma-
topontin, fibrinogen, glutathione S-transferase Mu 1, per-
oxiredoxin-2, serotransferrin, transgelin and vimentin;
Table 3).
Correlation analysis revealed strong (P\ 0.001; mean
q = 0.03) associations between lipid and vitamin status,
and aorta protein expression (Table 4). Protein expression
in the aorta was exclusively correlated with aorta adven-
titial lipid levels (total fat, cholesterol, HDL, NEFA) and
with the proportion of saturated and monounsaturated fat.
Figure 3 constructed from biochemical and aorta protein
correlations demonstrates the impact that B vitamins,
homocysteine and methionine cycle intermediates have on
lipoprotein accumulation directly in aorta adventitial lipid
(e.g., increased SATFAs, decreased MUFAs, increased
total cholesterol) and the influence that aorta lipid levels
have on the expression of more than 80 aorta proteins
(identified by spot number in Supplementary Table 1).
Discussion
The primary aim of this study was to examine and quantify
the differential effects of folate and/or B vitamin depletion
on global protein expression in the aorta of ApoE mice and
to consider the role of these proteins on cellular processes
implicated in human vascular disease. Feeding a folate and/
or B vitamin depleted diet against a control fat background
altered expression of only very few aorta protein [fibrino-
gen, gelsolin, lactate dehydrogenase, talin (upregulated)
and peptidyl-prolyl cis–trans isomerise (decreased)].
However, when combined with a major dietary challenge
(a high-fat diet), B vitamin depletion strongly perturbed
many more processes [including oxidative stress, inflam-
mation and vascular smooth muscle cell (VSMC) activa-
tion and migration] causally associated both with rodent
and human atherosclerosis (see Fig. 2). Suboptimum folate
status and hyperhomocysteinemia are linked with hyper-
lipidemia and oxidative stress, major risk factors for vas-
cular disease (Kris-Etherton et al. 2002; Lohm et al. 2002;
Mikael et al. 2006; Devlin et al. 2007). Here, B vitamin
depletion was associated with significant changes in vas-
cular adventitial lipid metabolism and protein markers of
Table 2 Correlation analyses of B vitamin, lipid status and athero-
sclerotic plaque formation in ApoE null mice
Biomarker Correlation P value
Plaque associations
Plaque abundance Plasma HDL 0.763 8E-12
Plaque abundance Plasma LDL 0.736 5E-10
Plaque abundance Plasma total
cholesterol
0.708 1.3E-
08
Plaque abundance Adventitia total
cholesterol
0.586 2.1E-
06
Plaque abundance Adventitia HDL 0.446 0.00055
Plaque abundance Plasma TG -0.427 0.00106
Plaque abundance Adventitia SATFA 0.374 0.00526
Plaque abundance Plasma B12 -0.271 0.04303
B vitamin status and lipid metabolism
Adventitia total
cholesterol
Plasma B12 -0.339 0.00802
Adventitia SATFA Whole blood B12 -0.632 1.3E-
07
Adventitia SATFA Plasma
homocysteine
0.534 1.9E-
05
Adventitia SATFA Plasma B12 -0.502 6.8E-
05
Adventitia SATFA Plasma folate -0.396 0.00231
Adventitia MUFA Plasma
homocysteine
-0.564 4.8E-
06
Adventitia MUFA Plasma B12 0.456 0.00037
Adventitia MUFA Whole blood B12 0.445 0.00052
Analysis of associations between blood B vitamin status markers and
blood, vascular lipids and plaque formation were carried out for all
mice in all treatment groups using Pearson’s correlation coefficients.
Biomarker and strength of associations (Pearson’s correlation coef-
ficient; positive and negative) are shown together with the corre-
sponding P value. B12 vitamin B12, HDL high-density lipoprotein,
LDL low-density lipoprotein, MUFAs monounsaturated fatty acids,
PUFAs polyunsaturated fatty acids, NEFA non-esterified fatty acids,
SATFAs saturated fatty acids
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cellular stress known to be altered in atherosclerosis
(Brownlee 2001; Vikramadithyan et al. 2005) only when
combined with this additional oxidative insult. Glutathione
S-transferase Mu was elevated, as was aldose reductase, a
protein that induces atherosclerosis in mice (Vikramadith-
yan et al. 2005) and is upregulated in human foam cells and
plaque macrophages (Gleissner et al. 2008). Peroxiredoxin
expression was decreased in this study. Low peroxiredoxin
expression is associated with atherosclerosis in mice and
humans (Gleissner et al. 2008). Elevated serotransferrin is
linked with oxidative stress and chronic disease risk.
Multiple aorta spots were identified as serotransferrin in
this study and feeding a high-fat/B vitamin-depleted diet
increased expression of each of these (P\ 0.05). More-
over, serotransferrin expression was positively associated
with total cholesterol and HDL accumulation in the
adventitia and negatively linked with monounsaturated
fatty acid concentration. Collective changes in these pro-
teins indicate an upregulated metabolic response to
hyperlipidemia in the aorta and an increased requirement to
resist vascular ROS generation.
Inflammation and accelerated growth and migration of
VSMC are critical in the progression of atherosclerosis.
Here, combined B vitamin depletion altered expression of
multiple protein molecular markers indicative both of a
pro-inflammatory environment and a pro-proliferative
VSMC phenotype. Annexin A1 (lipocortin), a potent anti-
inflammatory agent (Perretti and Dalli 2009) is present in
human atherosclerotic plaques, with low protein levels
indicative of advanced disease (Cheuk and Cheng 2011).
Lipocortin was negatively associated with adventitial
cholesterol accumulation. Atherosclerosis-driven inflam-
mation increases expression of acute phase proteins
including fibrinogen, C-reactive protein and serotransfer-
rin. Hyperfibrinogenemia is a marker for advanced human
atherosclerosis and a predictor for cardiovascular events
(Kofoed et al. 2003; Sabeti et al. 2005). Protein-glutamine
gamma-glutamyltransferase 2 (fibrinogen-stabilising fac-
tor) promotes fibrin deposition within the arterial lumen
and vascular endothelial cell dysfunction, VSMC prolif-
eration and atherosclerosis (Smith 1995). Here, fibrinogen
and fibrinogen-stabilising factor protein expression
increased and was positively linked with total and HDL
cholesterol and with reduced MUFA concentrations. Spe-
cific heat shock proteins (including Hsp60 and Hsp70) are
elevated in early human cardiovascular disease and are
predictive for atherosclerotic progression (Xu 2002;
Pockley et al. 2003). Hsp70 (identified here as 78 kDa
Cytoskeleton & cell molity (35%)
Dermaponn
Destrin
Dihydropyriminidinase-related protein 3
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Moesin
Myosin regulatory light polypepde 6
Myosin regulatory light polypepde 9
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WD repeat containing protein 1
Cell signalling, cell cycle &
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Collagen α-1(XVIII) chain
GTP-binding nuclear protein Ran
Heat shock protein 1Β
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Prolyl 4-hydroxylase β polypepde
Ligand transport (7%)
serotransferrin
Cellular metabolism (25%)
Aldose reductase
Electron transfer flavoprotein subunit α
S-formylglutathione hydrolase
Glutamate dehydrogenase 1
Glyceraldehyde-3-phosphate dehydrogenase
Isocitrate dehydrogenase
Isovaleryl-CoA dehydrogenase
L-lactate dehydrogenase
Pyruvate kinase isozymes M1/M2
Triosephosphate isomerase
Transcripon & protein metabolism (5%)
78 kDa glucose regulated protein
Pepdyl-prolyl cis-trans isomerase A
Protein-glutamine gamma-glutamyltransferase 2
Coagulaon, cell adhesion & chemotaxis (5%)
Fibrinogen β polypepde
Aorta
Fig. 2 Proteins and major cellular pathways altered by folic acid, B
vitamins and fat intake in aorta from ApoE null mice. All proteins
(influenced by treatment and associated with B vitamin and lipid
status at the end of intervention), together with primary cellular
function are presented as percentage of total identified proteins
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glucose-related proteins and Hsp 1B) and stress-induced
phosphoprotein 1 (a modulator of Hsp70 activity) were
positively associated with total and HDL adventitial cho-
lesterol and negatively linked with MUFA concentration.
Rho GDP dissociation inhibitor 1 negatively regulates
VSMC adhesion and enhances migration (Qi et al. 2008).
Here, feeding a high-fat combined B vitamin-depleted diet
significantly downregulated Rho GDP dissociation inhibi-
tor 1 expression in mouse aorta. Conversely, GTP-binding
nuclear protein Ran expression is positively associated
with VSMC migration (Fuastino et al. 2010). GTP-binding
nuclear protein Ran expression was upregulated in this
experiment. Actin assembly and disassembly drives vas-
cular cytoskeletal organisation and regulates VSMC
phenotype. Many aorta proteins (including transgelin,
vimentin, dermatopontin, collagen, moesin, myosin regu-
latory light polypeptide 6 and 9, and talin) that influence
actin filament regulation, cell differentiation, cell adhesion
and cell migration were altered by treatment in this study.
Reduced expression of transgelin-1 (sm22a) is related to
VSMC proliferation and atherosclerotic plaque formation
(Feil et al. 2004; Shen et al. 2010). Transgelin expression
was strongly downregulated in the aorta of mice fed a high-
fat and combined B vitamin-depleted diet. Moreover, a
strong negative relationship between transgelin and satu-
rated fatty acid accumulation in adventitial lipid was
observed. Overexpression of gelsolin increases vascular
endothelial cell motility (Silacci et al. 2003). Gelsolin was
Table 4 Associations
(correlation analyses) between
aorta lipid and aorta protein
expression
Analysis of associations
between aorta tissue protein
expression and vascular lipids
was carried out for all mice in
all treatment groups using
Pearson’s correlation
coefficients. Lipid biomarker,
spot number, protein name and
strength of association (positive
and negative) are shown
together with the corresponding
P value. B12 vitamin B12, HDL
high-density lipoprotein, LDL
low-density lipoprotein, MUFAs
monounsaturated fatty acids,
PUFAs polyunsaturated fatty
acids, NEFA non-esterified fatty
acids, SATFAs saturated fatty
acids
Biomarker Spot Protein Correlation P value
Adventitia total
cholesterol
829 Annexin A1 -0.500 4.69E-05
Adventitia total
cholesterol
582 Protein-glutamine gamma-
glutamyltransferase 2
0.413 0.00102
Adventitia total
cholesterol
912 Isocitrate dehydrogenase 0.418 0.00088
Adventitia total
cholesterol
524 Pyruvate kinase isozymes M1/M2 0.421 0.00079
Adventitia total
cholesterol
468 78 kDa glucose-regulated protein 0.424 0.00072
Adventitia total
cholesterol
473 Heat shock protein 1B 0.450 0.00030
Adventitia total
cholesterol
604 Glutamate dehydrogenase 1 0.472 0.00013
Adventitia total
cholesterol
557 Fibrinogen b polypeptide 0.484 9.09E-05
Adventitia total
cholesterol
812 Electron transfer flavoprotein subunit a 0.495 5.85E-05
Adventitia total
cholesterol
409 Serotransferrin 0.545 6.68E-06
Adventitia HDL 557 Fibrinogen b polypeptide 0.461 0.00020
Adventitia HDL 468 78 kDa glucose-regulated protein 0.556 4.02-06
Adventitia HDL 409 Serotransferrin 0.676 3.14E-09
Adventitia HDL 473 Heat shock protein 1B 0.687 1.30E-09
Adventitia NEFA 914 Vimentin -0.451 0.00030
Adventitia NEFA 772 Aldose reductase 0.414 0.00101
Adventitia NEFA 812 Electron transfer flavoprotein subunit a 0.443 0.00038
Adventitia NEFA 468 78 kDa glucose-regulated protein 0.471 0.00014
Adventitia NEFA 524 Pyruvate kinase isozymes M1/M2 0.472 0.00014
Adventitia NEFA 604 Glutamate dehydrogenase 1 0.487 8.32E-05
Adventitia NEFA 912 Isocitrate dehydrogenase 0.497 5.45E-05
Adventitia NEFA 909 GTP-binding nuclear protein Ran 0.573 1.71E-06
Adventitia MUFA 557 Fibrinogen b polypeptide -0.467 0.00024
Adventitia MUFA 410 Serotransferrin -0.457 0.00035
Adventitia MUFA 503 Stress-induced-phosphoprotein 1 -0.429 0.00085
Adventitia SATFA 1,125 Transgelin -0.512 4.72E-05
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elevated in the aorta of ApoE null mice in this study. While
collagen deposition is associated both with plaque forma-
tion and stability, polymerised collagen type 1 maintains
VSMC quiescence (Adiguzel et al. 2009). Here, expression
of this anti-proliferative and anti-inflammatory protein was
significantly decreased. Dermatopontin, an extracellular
matrix protein, regulates collagen deposition and promotes
cell adhesion (Okamoto et al. 2010), while moesin, a
member of the ezrin/radixin/moesin (ERM) protein family
(together with Rho GDP dissociation inhibitor 1), inhibits
cell migration (Takahashi et al. 1997). Feeding a high-fat B
vitamin-depleted diet decreased aorta moesin and derma-
topontin levels and (as described previously) Rho GDP
dissociation inhibitor 1 expression. Conversely, expression
of talin, a cytoskeletal protein which promotes cell dis-
persal (Albiges-Rizo et al. 1995) was doubled.
These parallel quantitative changes in numerous pro-
teins implicated in VSMC proliferation and motility pro-
vide strong but indirect evidence that feeding a combined B
vitamin-depleted high-fat diet may promote an invasive
VSMC phenotype in mice vivo. Whether B vitamin
depletion impacts on human aorta protein expression and
on SMC phenotype in the same way remains to be estab-
lished. ApoE null mice are recognised as a good model for
human vascular disease, spontaneously developing ath-
erosclerotic plaques morphologically similar to lesions
found in humans (Zhang et al. 2002). Additionally, here,
we have employed a nutritionally relevant nutritional
rodent model that better reflects a moderate B vitamin
deficiency when compared with previous studies inducing
supraphysiologically high levels of homocysteine (McNeil
et al. 2011). Furthermore, our findings are consistent with
Fig. 3 Association network 1 (ball and stick) of aorta proteins
influenced by B vitamin and fat intake in ApoE null mice. Association
networks between biochemical biomarkers and protein expression
were displayed using Cytoscape software (version 2.8.3; http://www.
cytoscape.org). Lines connecting proteins and biomarkers indicate a
correlation with R[ 0.3 or\-0.3. ACH adventitial total cholesterol,
AHDL adventitial high-density lipoprotein, AMF adventitial mono-
unsaturated fatty acid, ANF adventitial non-esterified fatty acid, APF
adventitial polyunsaturated fatty acid, ASF adventitial saturated fatty
acid, ATF adventitial total fat, ATG adventitial triglyceride, B12
vitamin B12, HDL high-density lipoprotein, Hcy homocysteine, LDL
low-density lipoprotein, SAH S-adenosylhomocysteine, SAM S-
adenosylmethionine, SAM: SAH S-adenosylmethionine: S-adenosyl-
homocysteine ratio, TC total cholesterol, TG triglyceride. Spot num-
ber and protein name: 409, serotransferrin; 410, serotransferrin; 411,
glyceraldehyde-3-phosphate dehydrogenase; 438, moesin; 468,
78 kDa glucose-regulated protein; 473, heat shock protein 1b, 479,
WD repeat-containing protein 1; 503, stress-induced-phosphoprotein
1; 507, transforming growth factor b-induced; 524, pyruvate kinase
isozymes M1/M2; 557, fibrinogen B b polypeptide isoforms; 582,
protein-glutamine gamma-glutamyltransferase 2; 604, glutamate
dehydrogenase 1; 682, serotransferrin; 711, isovaleryl-CoA dehy-
drogenase; 752, vimentin; 772, aldose reductase; 812, electron
transfer flavoprotein subunit a; 813, S-formylglutathione hydrolase;
829, annexin A1; 875, Rho GDP dissociation inhibitor 1; 887, glu-
tathione S-transferase Mu 1; 890, collagen a-1(XVIII) chain; 909,
GTP-binding nuclear protein Ran; 912, isocitrate dehydrogenase; 924,
peroxiredoxin-2; 938, vimentin; 1,060, transgelin; 1,085, myosin
regulatory light polypeptide 9; 1,125, transgelin; 1,126, myosin light
polypeptide 6; 1,169, dermatopontin
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other studies using proteomic technologies to profile aorta
or plasma protein expression patterns in several human
vascular pathologies. Many proteins, acknowledged as
characteristic of vascular disease progression, are identified
in this animal study as strongly linked to nutritional B
vitamin depletion (noted in parentheses). Medial degener-
ation in the human ascending aorta alters the expression of
proteins critical in vascular remodelling, cytoskeleton
organisation and muscle contraction (actin, collagen, pro-
filin, myosin, vimentin), VSMC phenotype (transgelins),
protein folding and ROS detoxification (Hsps, peroxire-
doxin, protein disulphide isomerase), and iron transport and
inflammation (serotransferrin) (Mayr et al. 2005). The
HUPO Plasma Proteome Project identified more than 300
human plasma proteins as strong biomarkers of vascular
function and/or disease. These include markers of inflam-
mation (transferrin), coagulation (fibrinogen A a-polype-
tide, fibronectin) and cytoskeletal organisation (actin,
myosin, talin and villin) (Sanzen et al. 2010). Protein
profiling has also been employed to investigate mechanism
of vascular dysfunction in animal models. Serotransferrin,
78 kDa glucose-regulated protein and pyruvate kinase
isozyme M1/M2 are elevated in experimentally induced rat
heart failure (Ingwall and Weiss 2004), while fibrinogen,
collagen, peroxidase and transgelin are overexpressed in
atherosclerotic mice (Mayr et al. 2005; Wu et al. 2007).
Transgelin-1 is increased in the artery wall of hypertensive
rats (Delbosc et al. 2008).
In summary, nutritional B vitamin depletion when
combined with a high-fat diet in a mouse model of human
vascular disease quantifiably altered the expression of
many aorta proteins implicated in human atherosclerosis,
primarily proteins associated with regulating the VSMC
phenotype. It remains to be established whether these
significant changes in vascular protein expression are dri-
ven by elevated homocysteine or are a consequence of
other B vitamin-sensitive mechanisms.
Acknowledgments This work was funded by The Scottish Gov-
ernment Rural and Environment Science and Analytical Services
Division (RESAS).
Conflict of interest All institutional and national guidelines for the
care and use of laboratory animals were followed. Susan Duthie, John
H Beattie, Margaret-J Gordon, Lynn P Pirie, Fergus Nicol, Martin D
Reid, Gary J Duncan, Louise Cantlay, Graham Horgan and Christo-
pher J McNeil declare that they have no conflict of interest.
References
Adiguzel E, Ahmad PJ, Franco C, Bendeck MP (2009) Collagens in
the progression and complications of atherosclerosis. Vasc Med
14:73–89
Albiges-Rizo C, Frachet P, Block MR (1995) Down regulation of
talin alters cell adhesion and the processing of the a5b1 integrin.
J Cell Sci 108:3317–3329
Almofti MR, Huang Z, Yang P, Rui Y (2006) Proteomic analysis of
rat aorta during atherosclerosis induced injection by high
cholesterol diet and injection of vitamin D3. Clin Exp Pharmacol
Physiol 33:305–309
Beattie JH, Duthie SJ, Kwunm I-S, Ha T-Y (2009) Rapid quantifi-
cation of aortic lesions in ApoE-/-mice. J Vasc Res
46:347–352
Brownlee M (2001) Biochemistry and molecular cell biology of
diabetic complications. Nature 414:813–820
Burdge GC, Wright P, Jones AE, Wooten SA (2000) A method for
separation of phosphatidylcholine, triacylglycerol, non-esterified
fatty acids and cholesterol esters from plasma by solid phase
extraction. B J Nutr 84:781–787
Cheuk BL, Cheng SW (2011) Annexin A1 expression in atheroscle-
rotic carotid plaques and its relationship with plaque character-
istics. Eur J Vasc Endovasc Surg 41:364–371
Delbosc S, Haloui M, Louedec L, Dupuis M et al (2008) Proteomic
analysis permits the identification of new biomarkers of arterial
wall remodelling in hypertension. Mol Med 14:383–394
Devlin AM, Singh R, Wade RE, Innis SM et al (2007) Hypermethy-
lation of Fads2 and altered hepatic fatty acid and phospholipid
metabolism in mice with hyperhomocysteinemia. J Biol Chem
282:37082–37090
Durga J, Bots ML, Schouten EG, Kok FJ (2005) Low concentrations
of folate not hyperhomocysteinemia are associated with carotid
intima-media thickness. Atherosclerosis 179:285–292
Duthie SJ, Mavrommatis Y, Rucklidge G, Reid M et al (2008) The
response of human colonocytes to folate deficiency in vitro:
functional and proteomic analysis. J Proteome Res 7:3254–3266
Farina A, Chambrey A, Esposito S, Agozzino L et al (2010)
Proteomic profiling of medial degeneration in human ascending
aorta. Clin Biochem 43:387–396
Feil S, Hofmann F, Feil R (2004) SM22a modulates vascular smooth
muscle cell phenotype during atherogenesis. Circ Res
94:863–865
Folch J, Less M, Sloane-Stanley GH (1957) A simple method for the
isolation and purification of total lipids from animal tissues.
J Biol Chem 226:497–509
Fuastino RS, Stronger LNW, Richard MN, Czubryt MP, Ford DA
et al (2010) RanGAP-mediated nuclear protein import in
vascular smooth muscle cells is augmented by lysophosphati-
dylcholine. Mol Pharmacol 71:438–445
Gleissner CA, Sanders JM, Nadler J, Ley K (2008) Upregulation of
aldose reductase during foam cell formation as possible link
between diabetes, hyperlipidemia and atherosclerosis. Arterios-
cler Thromb Vasc Biol 28:1137–1143
Ingwall JS, Weiss RG (2004) Is the failing heart energy starved? On
using chemical energy to support cardiac function. Circ Res
95:135–145
Kofoed SC, Wittrup HH, Sillesen H, Nordestgaard BG (2003)
Fibrinogen predicts ischemic stroke and advanced atherosclero-
sis but not echolucent, rupture-prone carotid plaques. The
Copenhagen City Heart Study. Eur Heart J 24:567–576
Kris-Etherton PM, Etherton TD, Carlson J, Gardner C (2002) Recent
discoveries in inclusive food-based approaches and dietary
patterns for reduction in risk for cardiovascular disease. Curr
Opin Lipidol 13:397–407
Lohm M, Dubrovska G, Lauterbach B, Luftm FC et al (2002)
Perivascular fat releases a vascular relaxing factor. FASEB J
16:1057–1063
Mangoni AA, Sherwood RA, Asonganyi B, Swift CG (2005) Short-
term folic oral acid supplementation enhances endothelial
446 Page 10 of 11 Genes Nutr (2015) 10:446
123
function in patients with type 2 diabetes. Am J Hypertens
81:220–226
Mayr M, Chung Y-I, Mayr U, Yin X et al (2005) Proteomic and
metabolic analyses of atherosclerotic vessels from apolipopro-
tein E-deficient mice reveal alterations in inflammation, oxida-
tive stress and energy metabolism. Arterioscler Thromb Vasc
Biol 25:2135–2142
McNeil CJ, Beattie JH, Gordon M-J, Pirie LP et al (2011) Differential
effects of nutritional folic acid deficiency and moderate hype-
rhomocysteinemia on aortic plaque formation and genome-wide
DNA methylation in vascular tissue from ApoE-/-mice. Clin
Epigenet 2:361–368
McNeil CJ, Beattie JH, Gordon M-J, Pirie LP et al (2012) Nutritional
B vitamin deficiency disrupts lipid metabolism causing accu-
mulation of proatherogenic lipoproteins in the aorta adventitia of
ApoE null mice. Mol Nutr Food Res 56:1122–1130
Mikael LG, Genest J, Rozen R (2006) Elevated homocysteine reduces
apolipoprotein A-1 expression in hyperhomocysteinemic mice
and in males with coronary artery disease. Circ Res 98:564–571
Okamoto O, Hozumi K, Katagiri F, Takahashi N et al (2010)
Dermatopontin promotes epidermal keratinocyte adhesion via
a3b1 integrin and a proteoglycan receptor. Biochemistry
49:147–155
Perretti M, Dalli J (2009) Exploiting the annexin A1 pathway for the
development of novel anti-inflammatory therapeutics. Brit J
Pharmacol 158:936–946
Pockley AG, Georgiades A, Thulin T, de Faire U et al (2003) Serum
heat shock protein 70 levels predict the development of
atherosclerosis in subjects with established hypertension. Hyper-
tension 42:235–238
Qi Y-X, Qu M-J, Long D-K, Liu B et al (2008) Rho-GDP dissociation
inhibitor alpha down regulated by low shear stress promotes
vascular smooth muscle cell migration and apoptosis: a proteo-
mic analysis. Cardiovasc Res 80:114–122
Sabeti S, Exner M, Mlekusch W, Amighi J et al (2005) Prognostic
impact of fibrinogen in carotid atherosclerosis: non-specific
indicator of inflammation or independent predictor of disease
progression? Stroke 36:1400–1404
Sanzen Y, Ito M, Ohta M, Yoshida Y et al (2010) Functional
proteomic analysis of experimental autoimmune myocarditis-
induced chronic heart failure in the rat. Biol Pharm Bull
33:477–486
Shen J, Yang M, Ju D, Jiang H et al (2010) Disruption of SM22
promotes inflammation after artery injury via nuclear factor kb
activation. Circ Res 106:1351–1362
Silacci P, Mazzolai L, Gauci C, Stergiopulos N et al (2003) Gelsolin
superfamily proteins: key regulators of cellular functions. Cell
Mol Life Sci B 61:2614–2623
Smith EB (1995) Fibrinogen, fibrin and the arterial wall. Eur Heart J
16:11–15
Splaver A, Lamas GA, Hennekens CH (2004) Homocysteine and
cardiovascular disease: biological mechanisms, observational
epidemiology and the need for randomised trials. Am Heart J
148:34–40
Takahashi K, Sasaki T, Mammoto A, Takaishi K et al (1997) Direct
interaction of the Rho GDP dissociation inhibitor with ezrin/
radixin/moesin initiates the activation of the Rho small G
protein. J Biol Chem 272:23371–23375
Tawakol A, Migrino RQ, Aziz KS, Waitkowska W et al (2005) High
dose folic acid acutely improves coronary vasodilator functions
in patients with coronary artery disease. J Am Coll Cardiol
45:1580–1584
Till U, Rohl P, Jentsch A, Till H (2005) Decrease of carotid intima-
media thickness in patients at risk to cerebral ischemia after
supplementation with folic acid, vitamins B6 and B12. Athero-
sclerosis 181:131–135
Vikramadithyan RK, Hu Y, Noh H-L, Liang C-P et al (2005) Human
aldose reductase expression accelerates diabetic atherosclerosis
in transgenic mice. J Clin Invest 115:2434–2443
Voutilainen S, Lakka TA, Porkkala-Sarataho E, Rissanen T et al
(2000) Low serum folate concentrations are associated with an
excess incidence of acute coronary events: the Kuopio Ischaemic
Heart Disease Risk Factor Study. Eur J Clin Nutr 54:424–428
Voutilainen S, Virtanen JK, Rissanen TH, Alfthan G et al (2004)
Serum folate and homocysteine and the incidence of acute
coronary events: the Kuopio Ischaemic Heart Disease Risk
Factor Study. Am J Clin Nutr 80:317–323
Wu J, Liu W, Sousa E, Qiu Y et al (2007) Proteomic identification of
endothelial proteins isolated in situ from atherosclerotic aorta via
systemic perfusion. J Proteome Res 6:4728–4736
Xu Q (2002) Role of heat shock proteins in atherosclerosis.
Arterioscler Thromb Vasc Biol 22:1547–1559
Zhang SH, Reddick RL, Piedrahita JA, Maeda N (2002) Spontaneous
hypercholesterolemia and arterial lesions in mice lacking
apolipoprotein E. Science 258:468–471
Genes Nutr (2015) 10:446 Page 11 of 11 446
123
 1 
 
SSP 
Mr 
[exp] 
(kDa) 
Mr 
[theor] 
(kDa) pI 
Mowse 
score-
10Log P 
No. 
significant 
peptides 
matched 
Sequence 
coverage 
(%) Protein name 
Accession  
No 
Gene 
name Function 
409 82.172 78.814 7.12 120 8 11 Serotransferrin Q921I1 Tf Ligand transport 
410 82.110 78.814 7.23 223 8 14 Serotransferrin Q921I1 Tf Ligand transport 
411 81.927 36.093 7.35 254 7 32 
Glyceraldehyde-3-phosphate 
dehydrogenase P16858 Gapdh Intermediate metabolism 
438 74.343 67.708 7.38 73 6 12 Moesin P26041 Msn Structural, cytoskeleton & cell motility 
468 71.320 72.491 5.90 830 23 42 78 kDa glucose regulated protein P20029 Hspa5 
Transcription, protein modelling  & 
metabolism 
473 70.585 70.321 5.99 420 15 31 Heat shock protein 1β  Q3TU85 Hspa1a 
Cell signalling, cell cycle, cell 
proliferation 
479 68.584 66.918 6.70 295 13 28 WD repeat-containing protein 1 O88342 
 
Wdr1 
Structural, cytoskeleton and cell 
motility 
503 64.714 62.970 6.95 90 3 6 Stress-induced-phosphoprotein 1 Q60864 
Stip1 Cell signalling, cell cycle, cell 
proliferation 
507 63.649 59.029 6.60 96 5 10 
Transforming growth factor β-
induced Q3TDZ5 Tgfbi Structural, cytoskeleton & cell motility 
511 62.856 62.140 6.68 160 8 20 
Dihydropyrimidinase-related protein 
3 Q3TT92 Dpysl3 Structural, cytoskeleton & cell motility 
524 61.506 58.32 8.08 436 9 19 Pyruvate kinase isozymes M1/M2 P52480 Pkm2 Intermediate metabolism 
539 39.682 57.422 4.75 86 3 5 Prolyl 4-hydroxylase β polypeptide  Q922C8 P4hb 
Xenobiotic metabolism, oxidative 
stress & redox regulation 
557 57.425 55.402 6.45 263 9 27 Fibrinogen β polypeptide isoform Q3TGR2 Fgb 
Coagulation, cell adhesion and 
chemotaxis 
575 53.977 271.832 8.59 183 9 5 Talin-1 P26039 Tln1 Structural, cytoskeleton & cell motility 
582 54.337 78.167 5.29 283 9 18 
Protein-glutamine gamma-
glutamyltransferase 2 P21981 
Tgm2 Transcription, protein modelling  & 
metabolism 
604 51.976 61.640 7.40 213 13 22 Glutamate dehydrogenase 1 P26443 Glud1 Intermediate metabolism 
 2 
611 51.649 61.640 7.67 111 7 13 Glutamate dehydrogenase 1 P26443 Glud1 Intermediate metabolism 
657 46.175 80.997 9.14 290 10 22 Gelsolin Q6PAC1 Gsn Structural, cytoskeleton & cell motility 
682 45.519 78.814 7.32 93 6 19 Serotransferrin Q921I1 Tf Ligand transport 
711 43.060 46.596 6.82 233 11 39 Isovaleryl-CoA dehydrogenase Q9JHI5 Ivd Intermediate metabolism 
752 39.137 53.581 4.83 294 11 25 Vimentin P20152 Vim Structural, cytoskeleton & cell motility 
772 35.364 35.921 7.22 136 4 9 Aldose reductase P45376 Akr1b1 Intermediate metabolism 
812 31.725 35.358 7.27 151 4 15 
Electron transfer flavoprotein 
subunit α Q99LC5 
Etfa 
Intermediate metabolism 
813 31.779 31.870 7.09 106 5 30 S-formylglutathione hydrolase Q9R0P3 Esd Intermediate metabolism 
829 30.863 38.864 8.18 87 4 13 Annexin A1 P10107 Anxa1 
Cell signalling, cell cycle, cell 
proliferation 
875 27.728 23.319 5.33 168 8 37 Rho GDP-dissociation inhibitor 1 Q99PT1 Arhgdia 
Cell signalling, cell cycle, cell 
proliferation 
887 27.003 25.936 8.24 130 3 12 Glutathione S-transferase Mu 1 P10649 
Gstm1 Xenobiotic metabolism, oxidative 
stress & redox regulation 
890 26.971 19.145 8.62 134 4 26 Collagen α-1(XVIII) chain P39061 Col18a1 
Cell signalling, cell cycle, cell 
proliferation 
892 26.847 26.907 7.74 571 10 46 Triosephosphate isomerase P17751 Tpi1 Intermediate metabolism 
909 25.127 24.448 7.46 114 4 20 GTP-binding nuclear protein Ran P62825 Ran 
Cell signalling, cell cycle, cell 
proliferation 
912 24.986 47.044 7.59 195 10 32 Isocitrate dehydrogenase Q3TJ51 Idh1 Intermediate metabolism 
924 22.538 21.805 5.07 100 3 22 Peroxiredoxin-2 Q61171 Prdx2 
Xenobiotic metabolism, oxidative 
stress & redox regulation 
933 21.049 23.679 7.13 431 8 38 Transgelin-2 Q9WVA4 Tagln2 Structural, cytoskeleton & cell motility 
938 21.419 53.581 4.58 255 9 18 Vimentin P20152 Vim Structural, cytoskeleton & cell motility 
1060 18.376 22.487 8.11 198 8 42 Transgelin P37804 Tagln Structural, cytoskeleton & cell motility 
1085 18.422 19.767 4.74 244 6 40 
Myosin regulatory light polypeptide 
9 Q9CQ19 Myl9 Structural, cytoskeleton & cell motility 
1107 17.087 18.721 6.79 247 8 58 Destrin Q9R0P5 Dstn Structural, cytoskeleton & cell motility 
1114 16.503 18.131 7.62 109 4 26 Peptidyl-prolyl cis-trans isomerase A P17742 
Ppia Transcription, protein modelling  & 
metabolism 
1123 16.400 16.696 3.50 211 7 44 Calmodulin P62204 Calm1 Cell signalling, cell cycle, cell 
 3 
proliferation 
1125 15.724 22.487 8.17 144 6 34 Transgelin P37804 Tagln Structural, cytoskeleton & cell motility 
1126 16.012 17.121 4.21 316 8 47 Myosin light polypeptide 6 Q60605 Myl6 Structural, cytoskeleton & cell motility 
1169 22.888 24.563 4.26 186 6 29 Dermatopontin Q9QZZ6 Dpt Structural, cytoskeleton & cell motility 
1186 32.819 36.818 7.98 105 7 23 L-lactate dehydrogenase  Q3THB4 Ldha Intermediate metabolism 
1195 30.814 55.402 8.97 399 16 42 Fibrinogen β polypeptide Q3TGR2 Fgb 
Coagulation, cell adhesion & 
chemotaxis 
 
Supplementary Table 1. Measures of confidence for protein identification in aorta proteins significantly altered in response to folic acid, B vitamins and 
fat intake.  
Spot number, calculated and theoretical molecular weight (KDa) and pI are presented. Probability-based Mowse Scores for MS/MS-based identifications 
[where ion scores greater than 35 indicate identity of significant homology (P<0.05)], number of sequence peptides matched by “Mascot” searching (Matrix 
Science Ltd, Boston USA), percentage sequence coverage, accession number, gene and protein name are shown for all identified proteins.
